InterCure Ltd. — Form 6-K Summary
Business Context and Reporting Period
InterCure Ltd., an Israeli foreign private issuer, filed Form 6-K for the month of April 2023. The filing was submitted on April 25, 2023, under Commission File Number 001-40614. The company files annual reports on Form 20-F.
Financial Metrics
The filing text provided does not include revenue, profit, cash flow, margins, debt, liquidity, operating results, or other financial metrics.
Material Changes Versus Prior Period
The filing text does not provide information regarding changes from a prior comparable period.
Guidance, Outlook, Risks, and Unusual Items
The filing identifies an attached press release dated April 25, 2023, as Exhibit 99.1, but the press release content is not included in the provided filing text. Accordingly, guidance, outlook, management commentary, risks, contingencies, and unusual items cannot be assessed.
Investor Verification Items
- Review Exhibit 99.1 for the substantive disclosure associated with this filing.
- Verify whether the attached press release contains financial results, operational updates, guidance, or material events.
- Confirm any reported metrics and comparisons directly against the complete filing and press release.